Archive for the ‘rx’ Category

Merck will be collaborating with Neuromed to develop new treatments for chronic pain. The deal includes Neuromed’s leading compound NMED-160, currently mid-way through testing. These do sound quite hopeful, as Christopher Gallun, the CEO of Neuromed told the New York Times in an interview “We think these have the potential to become very powerful agents […]